Law Offices of Howard G. Smith reminds investors of the upcoming lead plaintiff deadline in the class action lawsuit filed on behalf of a class comprising purchasers of the securities of Solazyme, Inc. (“Solazyme” or the “Company”) (NASDAQ:SZYM) who purchased securities between February 27, 2014 and November 5, 2014, inclusive (the “Class Period”). Investors have until August 24, 2015 to file a motion to be appointed as a lead plaintiff in this class action lawsuit.

Solazyme is a bioproducts company that uses algae-based fermentation to produce renewable oils for a range of personal and industrial uses. The complaint alleges that throughout the Class Period, the Company made false and/or misleading statements, as well as failed to disclose material adverse facts about Solazyme's construction progress, development and production capacity at its renewable oils production facility located in Moema, Brazil (the "Moema Project"). Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: Solazyme misstated and/or failed or disclose unfavorable news about the Moema Project. Solazyme initially failed to report that the Moema Project suffered construction delays stemming from the inadequate availability of electricity and steam utilities. As a result, the lawsuit alleges that Solazyme was prevented from increasing output to its previously projected levels. On or around November 5, 2014, when the truth regarding the Moema Project was revealed to investors, the Company's stock declined $4.35 per share, or 58%, to close at $3.14 per share on November 6, 2014.

If you purchased Solazyme shares during the Class Period, if you have information or would like to learn more about these claims, or have any questions concerning this announcement, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.